Brief: Astrazeneca Pharma India March-Qtr PAT Rises
25/05/2021 12:06
May 25 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA MARCH-QUARTER PAT 272.8 MILLION
RUPEES
VERSUS PROFIT 95.8 MILLION RUPEES YEAR AGO
* ASTRAZENECA PHARMA INDIA MARCH-QUARTER REVENUE FROM
OPERATIONS
2.10 BILLION RUPEES VERSUS 1.95 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan